CARL vs IONS · rev $50.5M vs rev $514.0M
Carlsmed, Inc. Common Stock (CARL) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
Carlsmed, Inc. Common Stock (CARL) is a health information services company listed on NASDAQ.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported CARL revenue for 2025-12-31 was $50.5M. Net income was -$29.6M. Revenue was up 85.9% from 2024-12-31 to 2025-12-31. CARL currently screens at market cap $299.7M.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
CARL currently screens at market cap $299.7M. IONS currently screens at market cap $12.28B.
Not investment advice. Open the CARL and IONS stock pages for the full models.
Not investment advice.